The premium we said hadn't cracked just did

Three weeks ago, Fundrise's Innovation Fund (NYSE: VCX) had one date that mattered — around September 19, 2026, when the six-month lockup expires and roughly 100,000 pre-listing investors (cost basis ~$10–11) can finally sell. The strange part back then: the market wasn't pricing that supply wall at all. The premium sat near 356% and refused to move.

What changed

It moved. VCX has fallen from ~$86 in late June to about $58 as of July 20 — a 33% drop in three weeks. Against the fund's last-reported NAV of $18.43 (Fundrise's own Q1 figure), that's a premium of roughly 217%, down from ~356%. The market has begun front-running the unlock — the same pattern DXYZ, the closest analog vehicle, ran in 2024, when its premium collapsed 80%+ once unlock dynamics took hold.

Why it still matters

The compression has started, but the biggest block of supply is still ahead: those ~100,000 restricted holders can't sell until September. And the Citron overhang crystallized — Andrew Left was convicted of securities fraud on June 1 (guilty on 13 of 17 counts). Late buyers from June are already down 30%+, and the unlock sits on top of that.

The lesson isn't "Citron was right." It's that a 200%+ premium on an $18 NAV was always going to mean-revert — the only open question was whether before the date or after. It started before.

Read the full supply-wall breakdown →

— Jorge